» Articles » PMID: 27033089

Quercetin-3-O-rhamnoside from Euphorbia Hirta Protects Against Snake Venom Induced Toxicity

Overview
Specialties Biochemistry
Biophysics
Date 2016 Apr 2
PMID 27033089
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The plant Euphorbia hirta is widely used against snake envenomations in rural areas and it was proved to be effective in animal models. Therefore, the scientific validation of its phytoconstituents for their antiophidian activity is aimed in the present study.

Methods: E. hirta extract was subjected to bioactivity guided fractionation and the fractions that inhibited different enzyme activities of Naja naja venom in vitro was structurally characterized using UV, FT-IR, LC-MS and NMR spectroscopy. Edema, hemorrhage and lethality inhibition activity of the compound were studied in mice model. In addition, molecular docking and molecular dynamic simulations were also performed in silico.

Results: The bioactive fraction was identified as Quercetin-3-O-α-rhamnoside (QR, 448.38 Da). In vitro experiments indicated that protease, phospholipase-A(2), hemolytic activity and hemorrhage inducing activity of the venom were inhibited completely at a ratio of 1:20 (venom: QR) w/w. At the same concentration, the edema ratio was drastically reduced from 187% to 107%. Significant inhibition (93%) of hyaluronidase activity was also observed at a slightly higher concentration of QR (1:50). Further, in in vivo analysis, QR significantly prolonged the survival time of mice injected with snake venom.

Conclusion: For the first time Quercetin-3-O-α-rhamnoside, isolated from E. hirta, has been shown to exhibit anti-snake venom activity against Naja naja venom induced toxicity.

General Significance: Exploring such multifunctional lead molecules with anti-venom activity would help in developing complementary medicine for snakebite treatments especially in rural areas where anti-snake venom is not readily available.

Citing Articles

The Need for Next-Generation Antivenom for Snakebite Envenomation in India.

Vanuopadath M, Rajan K, Alangode A, Nair S, Nair B Toxins (Basel). 2023; 15(8).

PMID: 37624267 PMC: 10467155. DOI: 10.3390/toxins15080510.


Pharmacoinformatic Investigation of Silymarin as a Potential Inhibitor against Jellyfish Metalloproteinase Toxin-like Protein.

Asirvatham R, Hwang D, Prakash R, Kang C, Kim E Int J Mol Sci. 2023; 24(10).

PMID: 37240317 PMC: 10219531. DOI: 10.3390/ijms24108972.


In Vitro Anti-Venom Potentials of Aqueous Extract and Oils of M. Roem against Cobra Venom and Chemical Constituents of Oils.

Okot D, Namukobe J, Vudriko P, Anywar G, Heydenreich M, Omowumi O Molecules. 2023; 28(7).

PMID: 37049851 PMC: 10096364. DOI: 10.3390/molecules28073089.


Inflammation and Oxidative Stress in Snakebite Envenomation: A Brief Descriptive Review and Clinical Implications.

Resiere D, Mehdaoui H, Neviere R Toxins (Basel). 2022; 14(11).

PMID: 36422976 PMC: 9694585. DOI: 10.3390/toxins14110802.


Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.

Adriao A, Dos Santos A, de Lima E, Maciel J, Paz W, Silva F Front Immunol. 2022; 13:842576.

PMID: 35615352 PMC: 9126284. DOI: 10.3389/fimmu.2022.842576.